Capricor Therapeutics Total Liabilities

Capricor Therapeutics (CAPR) currently reports a total liabilities of $48M as of March 2026. That compares with $3.8B in the prior-year period — down 98.7% year over year. Use the charts on this page to explore Capricor Therapeutics's total liabilities history and peer comparisons.

Capricor Therapeutics's total liabilities decreased from $3.8B to $48M — a 98.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Capricor Therapeutics reported $48M in total liabilities as of March 2026. That compares with $3.8B in the prior-year period — down 98.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Capricor Therapeutics, and consider following CAPR for alerts when major investors trade the stock.

Capricor Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $48M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CAPR with unrelated industries.